An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Neeta Tandon, MA
Advertisement
Articles by Neeta Tandon, MA
Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.
Advertisement
Latest Updated Articles
- Rheumatoid Arthritis and Joint Replacement: Impact of Biologics
Published: December 16th 2014 | Updated:
- Direct and Indirect Cost Burden of Chronic Hepatitis C
Published: September 26th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Experimental Vaccine Shows 73% Efficacy Against Salmonella Paratyphi A
3
Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate
4
Tezepelumab Improves Asthma Control, Reduces Reliance on Oral Corticosteriods
5
